MOH — authorised 30 August 1985
- Marketing authorisation holder: RANBAXY
- Status: likely_approved
MOH authorised Exelderm on 30 August 1985
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 August 1985.
RANBAXY holds the Israeli marketing authorisation.